Virax Biolabs Group
VRAX • NASDAQ • Stock Fundamentals
Virax Biolabs Group is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James Foster, with a market cap of $935.4K.
Market Cap$935.4K
Employees11.0
CEOJames Foster
CountryUnited Kingdom
Healthcare
Biotechnology
Most Recent EarningsDec 2, 2025 · 5 months agoQ3 2025
View reportNext EarningsJun 3, 2026 · In 3 weeksQ1 2026
Financials
Based on Q3 2025 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metric
Virax Biolabs Group FAQ
Common questions about Virax Biolabs Group
Virax Biolabs Group (VRAX) has a market capitalization of $935.4K and trades on NASDAQ.
Virax Biolabs Group has approximately 11 employees.